Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
Sales | 1,015 | 5,254 | 3,861 | 4,590 | 2,412 |
Gross Profit | 1,015 | 5,254 | 3,861 | 4,590 | 2,412 |
Operating Expenses | 4,344 | 9,136 | 4,700 | 7,291 | 15,437 |
Operating Income | -3,329 | -3,882 | -839 | -2,701 | -13,025 |
Pre-tax Income | -3,329 | -3,882 | -839 | -2,701 | -13,025 |
Net Income Continuous | -3,329 | -3,882 | -839 | -2,701 | -13,025 |
Net Income Discontinuous | N/A | N/A | N/A | N/A | 1,073 |
Net Income | $-3,329 | $-3,882 | $-839 | $-11,155 | $-11,952 |
EPS Basic Total Ops | -1.16 | -1.36 | -0.28 | -3.96 | -4.24 |
EPS Basic Continuous Ops | -1.16 | -1.36 | -0.30 | -0.96 | -4.64 |
EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.40 |
EPS Diluted Total Ops | -1.16 | -1.36 | -0.28 | -3.96 | -4.24 |
EPS Diluted Continuous Ops | -1.16 | -1.36 | -0.30 | -0.96 | -4.64 |
EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.40 |
EBITDA(a) | $-3,251 | $-3,656 | $-173 | $-2,270 | $-12,617 |